Cargando…

Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a common abdominal cancer with dissatisfactory therapeutic effects. The discovery of cuproptosis lights on new approach for cancer treatment and assessment. So far, there is extremely limited research investigating the roles of cuproptosis-related (CR) g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Changwei, Dai, Shejiao, Xu, Fangshi, Yuan, Jia, Fan, Shuting, Chen, Yang, Yang, Longbao, Li, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824945/ https://www.ncbi.nlm.nih.gov/pubmed/36611155 http://dx.doi.org/10.1186/s12885-022-10461-2

Ejemplares similares

Commentary: Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints
por: Xu, Fangshi, et al.
Publicado: (2023)

Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma
por: Ding, Lei, et al.
Publicado: (2022)

Risk model of hepatocellular carcinoma based on cuproptosis-related genes
por: Liu, Zhiqiang, et al.
Publicado: (2022)

The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
por: Zhao, Xueying, et al.
Publicado: (2022)

The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma
por: Liu, Zhili, et al.
Publicado: (2023)

Creation of a Prognostic Model Using Cuproptosis-Associated Long Noncoding RNAs in Hepatocellular Carcinoma
por: Yang, Lihong, et al.
Publicado: (2023)

Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
por: Chen, Yuqiao, et al.
Publicado: (2023)

TIGD1 Function as a Potential Cuproptosis Regulator Following a Novel Cuproptosis-Related Gene Risk Signature in Colorectal Cancer
por: Wu, Zhiwei, et al.
Publicado: (2023)

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
por: Li, Xinqiang, et al.
Publicado: (2022)

A novel cuproptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma
por: Yang, Fan, et al.
Publicado: (2022)

Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma
por: Zhang, Zhen, et al.
Publicado: (2022)

Comprehensive multiomics analysis of cuproptosis-related gene characteristics in hepatocellular carcinoma
por: Fu, Jie, et al.
Publicado: (2022)

A prognostic signature of cuproptosis and TCA-related genes for hepatocellular carcinoma
por: Zhang, Qi, et al.
Publicado: (2022)

Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma
por: Tang, Xiaolong, et al.
Publicado: (2023)

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma
por: Zhou, Zheng, et al.
Publicado: (2022)

Prognostic Implication of a Cuproptosis-Related miRNA Signature in Hepatocellular Carcinoma
por: Jin, Ze, et al.
Publicado: (2022)

Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2022)

Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma
por: Zhu, Yuezhi, et al.
Publicado: (2023)

Genetic landscape and clinical significance of cuproptosis-related genes in liver hepatocellular carcinoma
por: Hu, Dingtao, et al.
Publicado: (2023)

Single-cell and genetic multi-omics analysis combined with experiments confirmed the signature and potential targets of cuproptosis in hepatocellular carcinoma
por: Cao, Feng, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
por: Wu, Jingyi, et al.
Publicado: (2023)

A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma
por: Chen, Shujia, et al.
Publicado: (2022)

Regulatory roles of copper metabolism and cuproptosis in human cancers
por: Wang, Zhe, et al.
Publicado: (2023)

Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
por: Huang, En-Min, et al.
Publicado: (2022)

A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma
por: Xie, Yusai, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma
por: Li, Duguang, et al.
Publicado: (2023)

Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma
por: Liangyu, Zhu, et al.
Publicado: (2023)

Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma
por: Chen, Xi, et al.
Publicado: (2022)

Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
por: Zhu, Hongfei, et al.
Publicado: (2022)

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma
por: Liu, Chunhua, et al.
Publicado: (2023)

Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma
por: Qi, Xiangjun, et al.
Publicado: (2022)

An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
por: Wang, Hongjin, et al.
Publicado: (2023)

A Novel Cuproptosis-Related Signature Identified DLAT as a Prognostic Biomarker for Hepatocellular Carcinoma Patients
por: Bai, Wen Dong, et al.
Publicado: (2022)

Ferroptosis and cuproptosis prognostic signature for prediction of prognosis, immunotherapy and drug sensitivity in hepatocellular carcinoma: development and validation based on TCGA and ICGC databases
por: Ma, Qi, et al.
Publicado: (2022)

Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis
por: Chen, Qiqi, et al.
Publicado: (2022)

FNBP4 is a Potential Biomarker Associated with Cuproptosis and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Zheng, Kai-Wen, et al.
Publicado: (2023)

A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma
por: Li, Yaoting, et al.
Publicado: (2023)

An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
por: Chen, Xilang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8g2tfvfgqjc1q2efs3q03mp66u